Meeting Attendance Grants

Meeting Attendance Grants enable early career researchers to attend microbiology meetings worldwide to network, collaborate and keep abreast of new developments in their field. Support is limited to a maximum of € 600.

Eligibility

Applicants should be active microbiologists, having obtained their highest degree less than five years prior to the application deadline date or be a PhD student. They should be a member of a FEMS Member Society and a presenting author (oral or poster) at the meeting. Applications to attend FEMS-sponsored meetings will not be considered as applications for support to attend these meetings should be made directly to the meeting organizer.

Grant Application

Complete applications should be submitted on or before the deadlines

  • 1 March for meetings that will be held within a year from the following 1 May
  • 1 September for meetings that will be held within a year from the following 1 November

You can apply for Meeting Attendance Grants starting 1 January 2018 via FEMS Grants Online. See more information about the grant and how to apply in the FEMS Grants Regulations.

If you have applied for a Meeting Attendance Grant before 1 November 2017, you can find your application information here.

Featured article

Strategies to combat antimicrobial resistance: anti-plasmid and plasmid curing

Antimicrobial resistance (AMR) is a global problem hindering treatment of bacterial infections, rendering many aspects of modern medicine less effective. AMR genes (ARGs) are frequently located on plasmids, which are self-replicating elements of DNA. They are often transmissible between bacteria, and some have spread globally. Novel strategies to combat AMR are needed, and plasmid curing and anti-plasmid approaches could reduce ARG prevalence, and sensitise bacteria to antibiotics. Currently, there is a general lack of in vivo curing options. This review highlights this important shortfall, which if filled could provide a promising mechanism to reduce ARG prevalence in humans and animals. Plasmid curing mechanisms which are not suitable for in vivo use could still prove important for reducing the global burden of AMR, as high levels of ARGs exist in the environment.

read more
More articles
more articles